[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  DonCorleone77 [@CorleoneDon77](/creator/twitter/CorleoneDon77) on x 5467 followers Created: 2025-07-17 00:51:34 UTC $CRM Attached is page X of a 16-page Citizens analyst report on CRM issued today entitled: "Top X Insights from Our Chat with Richard Socher, Former Chief Scientist of Salesforce" Citizens has a 'Market Outperform' rating on CRM with a $XXX price target. Citizens' 'Investment Highlights' regarding CRM in the report includes the following: "We maintain our Market Outperform rating and $XXX price target on Salesforce after hosting a fireside chat yesterday at the Citizens Technology Forum, held at the Solage Resort in Calistoga, California, with Richard Socher, the CEO and founder of General Partner and founder of AIX Ventures, former EVP and Chief Scientist at Salesforce (from 2016–2020), and a highly influential AI researcher who received his PhD in Computer Science from Stanford University, and after the stock has fallen XX% year to date versus a X% increase for the S&P XXX and X% increase for the Russell 3000. • We maintain our FY26 non-GAAP EPS estimate of $XXXXX (consensus $11.31) on revenue growth of 9%, maintain our FY27 non-GAAP EPS estimate of $XXXXX (consensus $12.65) on revenue growth of 10%, and maintain our FY28 non-GAAP EPS estimate of $XXXXX (consensus $14.40) on revenue growth of 12%. • Salesforce trades at a CY26E EV/revenue multiple of 5.2x and a CY26E EV/FCF multiple of 16x, while our $XXX price target implies a CY26E EV/revenue multiple of 8.9x and a CY26E EV/free cash flow multiple of 27x, a roughly XX% discount to the large-cap software peer group that we believe is justified by Salesforce's slower relative growth rate. -- Risks to investing in include: 1) operational and execution risks including service disruptions and security breaches; 2) strategic and industry risks like competition; 3) legal and regulatory risks, including privacy concerns; 4) financial risks like disappointing growth or margins; 5) risks related to owning the common stock like provisions in the company's bylaws or certificate of incorporation that might discourage a change in control of the company or changes in management." (Page X is not available here as X does not allow me to post pages from reports on this platform) XXX engagements  **Related Topics** [investment](/topic/investment) [$crm](/topic/$crm) [salesforce](/topic/salesforce) [stocks technology](/topic/stocks-technology) [Post Link](https://x.com/CorleoneDon77/status/1945647530282225695)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
DonCorleone77 @CorleoneDon77 on x 5467 followers
Created: 2025-07-17 00:51:34 UTC
$CRM
Attached is page X of a 16-page Citizens analyst report on CRM issued today entitled:
"Top X Insights from Our Chat with Richard Socher, Former Chief Scientist of Salesforce"
Citizens has a 'Market Outperform' rating on CRM with a $XXX price target.
Citizens' 'Investment Highlights' regarding CRM in the report includes the following:
"We maintain our Market Outperform rating and $XXX price target on Salesforce after hosting a fireside chat yesterday at the Citizens Technology Forum, held at the Solage Resort in Calistoga, California, with Richard Socher, the CEO and founder of General Partner and founder of AIX Ventures, former EVP and Chief Scientist at Salesforce (from 2016–2020), and a highly influential AI researcher who received his PhD in Computer Science from Stanford University, and after the stock has fallen XX% year to date versus a X% increase for the S&P XXX and X% increase for the Russell 3000.
• We maintain our FY26 non-GAAP EPS estimate of $XXXXX (consensus $11.31) on revenue growth of 9%, maintain our FY27 non-GAAP EPS estimate of $XXXXX (consensus $12.65) on revenue growth of 10%, and maintain our FY28 non-GAAP EPS estimate of $XXXXX (consensus $14.40) on revenue growth of 12%.
• Salesforce trades at a CY26E EV/revenue multiple of 5.2x and a CY26E EV/FCF multiple of 16x, while our $XXX price target implies a CY26E EV/revenue multiple of 8.9x and a CY26E EV/free cash flow multiple of 27x, a roughly XX% discount to the large-cap software peer group that we believe is justified by Salesforce's slower relative growth rate.
-- Risks to investing in include:
- operational and execution risks including service disruptions and security breaches;
- strategic and industry risks like competition;
- legal and regulatory risks, including privacy concerns; 4) financial risks like disappointing growth or margins;
- risks related to owning the common stock like provisions in the company's bylaws or certificate of incorporation that might discourage a change in control of the company or changes in management."
(Page X is not available here as X does not allow me to post pages from reports on this platform)
XXX engagements
Related Topics investment $crm salesforce stocks technology